Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocytes”

1,747 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,747 results

Testing effectiveness (Phase 2)Study completedNCT00566098
What this trial is testing

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Not applicableStudy completedNCT00618267
What this trial is testing

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

Who this might be right for
Multiple Sclerosis
Biogen 100
Not applicableStudy completedNCT04879316
What this trial is testing

Energy for Lymphocytes

Who this might be right for
Non-small Cell Lung CancerProgression, Disease
Hôpital Cochin 144
Testing effectiveness (Phase 2)Study completedNCT00923845
What this trial is testing

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Who this might be right for
Renal Cell CarcinomaGraft-Versus-Host DiseaseEngraftment Syndrome
National Cancer Institute (NCI) 25
Not applicableUnknownNCT03725137
What this trial is testing

Post-stroke Immunological Changes in Young Stroke Patients

Who this might be right for
Stroke, IschemicCognitive Decline
University Medicine Greifswald 77
Testing effectiveness (Phase 2)Study completedNCT00070304
What this trial is testing

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 33
Not applicableStudy completedNCT05610592
What this trial is testing

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Who this might be right for
Tumor BuddingRectal Cancer
Sun Yat-sen University 480
Testing effectiveness (Phase 2)Study completedNCT02640807
What this trial is testing

IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients

Who this might be right for
Severe Sepsis With Septic Shock
Revimmune 27
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Testing effectiveness (Phase 2)UnknownNCT04896606
What this trial is testing

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Who this might be right for
Covid19
New York Medical College 50
Not applicableStudy completedNCT02126384
What this trial is testing

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response

Who this might be right for
Pneumococcal Diseases
Institut National de la Santé Et de la Recherche Médicale, France 9
Testing effectiveness (Phase 2)Study completedNCT00381940
What this trial is testing

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+17 more
National Cancer Institute (NCI) 26
Not applicableLooking for participantsNCT07087093
What this trial is testing

Effects of Ketone Esters on Circulating Senescent T Lymphocytes (T Cells) and Inflammation Levels in the Elderly

Who this might be right for
The Elderly
First Affiliated Hospital of Harbin Medical University 20
Not applicableLooking for participantsNCT06253338
What this trial is testing

Optimization of Radiation Protection Through Genomic Analyses

Who this might be right for
DNACancerRadiation
University Hospital, Essen 30
Not applicableNot Yet RecruitingNCT07000396
What this trial is testing

The Role of Mucosal Associated Invariant t Lymphocytes in Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 74
Post-approval studies (Phase 4)WithdrawnNCT05180318
What this trial is testing

Prophylactic Effects of Esketamine in Surgical Patients

Who this might be right for
Surgical Injury
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Very early researchLooking for participantsNCT07349160
What this trial is testing

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Testing effectiveness (Phase 2)Study completedNCT01541280
What this trial is testing

VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Nantes University Hospital 30
Not applicableStudy completedNCT00820820
What this trial is testing

IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Institut National de la Santé Et de la Recherche Médicale, France 20
Testing effectiveness (Phase 2)Ended earlyNCT02062359
What this trial is testing

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma

Who this might be right for
Metastatic CancerMetastatic Melanoma
National Cancer Institute (NCI) 2
Load More Results